-
1
-
-
29144482046
-
Prognostic factors and survival in endocrine tumor patients: Comparison between gastrointestinal and pancreatic localization
-
Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005;12:1083-92.
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 1083-1092
-
-
Panzuto, F.1
Nasoni, S.2
Falconi, M.3
Corleto, V.D.4
Capurso, G.5
Cassetta, S.6
-
2
-
-
0032887684
-
Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
-
Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, et al. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 1999;40(10):1602-8.
-
(1999)
J Nucl Med
, vol.40
, Issue.10
, pp. 1602-1608
-
-
Lebtahi, R.1
Cadiot, G.2
Delahaye, N.3
Genin, R.4
Daou, D.5
Peker, M.C.6
-
3
-
-
0027999468
-
[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: The predictive value for somatostatin analogue treatment
-
Janson ET,Westlin JE, Eriksson B, Ahlström H, Nilsson S, Öberg K. [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment. Eur J Endocrinol 1994;131(6):577-81.
-
(1994)
Eur J Endocrinol
, vol.131
, Issue.6
, pp. 577-581
-
-
Janson, E.T.1
Westlin, J.E.2
Eriksson, B.3
Ahlström, H.4
Nilsson, S.5
Öberg, K.6
-
4
-
-
0031910371
-
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours
-
Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 1998;25(1):79-83.
-
(1998)
Eur J Nucl Med
, vol.25
, Issue.1
, pp. 79-83
-
-
Adams, S.1
Baum, R.2
Rink, T.3
Schumm-Dräger, P.M.4
Usadel, K.H.5
Hör, G.6
-
5
-
-
0031900605
-
Neuroendocrine tumour imaging: Can 18Ffluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior
-
Pasquali C, Rubello D, Sperti C, Gasparoni P, Liessi G, Chierichetti F, et al. Neuroendocrine tumour imaging: can 18Ffluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior. World J Surg 1998;22:588-92.
-
(1998)
World J Surg
, vol.22
, pp. 588-592
-
-
Pasquali, C.1
Rubello, D.2
Sperti, C.3
Gasparoni, P.4
Liessi, G.5
Chierichetti, F.6
-
6
-
-
0014510423
-
The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept
-
Pearse AG. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 1969;17(5):303-8.
-
(1969)
J Histochem Cytochem
, vol.17
, Issue.5
, pp. 303-308
-
-
Pearse, A.G.1
-
7
-
-
0029971787
-
In vivo demonstration of enzyme activity in endocrine pancreatic tumors: Decarboxylation of carbon-11- DOPA to carbon-11-dopamine
-
Bergström M, Eriksson B, Öberg K, Sundin A, Ahlström H, Lindner KJ, et al. In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11- DOPA to carbon-11-dopamine. J Nucl Med 1996;37(1):32-7.
-
(1996)
J Nucl Med
, vol.37
, Issue.1
, pp. 32-37
-
-
Bergström, M.1
Eriksson, B.2
Öberg, K.3
Sundin, A.4
Ahlström, H.5
Lindner, K.J.6
-
8
-
-
84865304110
-
111In-DTPA0-octreotide (Octreoscan) 131I-MIBG and other agents for radionuclide therapy of NETs
-
Bomanji JB, Papathanasiou ND. 111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs. Eur J Nucl Med Mol Imaging 2012;39 Suppl 1: S113-25.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, Issue.SUPPL. 1
-
-
Bomanji, J.B.1
Papathanasiou, N.D.2
-
9
-
-
14844323979
-
Developments in PET for the detection of endocrine tumours
-
Eriksson B, Örlefors H, Oberg K, Sundin A, Bergström M, Langström B. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab 2005;19 (2):311-24.
-
(2005)
Best Pract Res Clin Endocrinol Metab
, vol.19
, Issue.2
, pp. 311-324
-
-
Eriksson, B.1
Örlefors, H.2
Oberg, K.3
Sundin, A.4
Bergström, M.5
Langström, B.6
-
10
-
-
35348832968
-
The effects of carbidopa on uptake of 6-18Ffluoro- L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma
-
Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, et al. The effects of carbidopa on uptake of 6-18Ffluoro- L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. J Nucl Med 2007;48:1599-606.
-
(2007)
J Nucl Med
, vol.48
, pp. 1599-1606
-
-
Timmers, H.J.1
Hadi, M.2
Carrasquillo, J.A.3
Chen, C.C.4
Martiniova, L.5
Whatley, M.6
-
11
-
-
19644398630
-
Characterization of hyperinsulinism in infancy assessed with PET and 18-fluoro-L-DOPA
-
Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18-fluoro-L-DOPA. J Nucl Med 2005;46:560-6.
-
(2005)
J Nucl Med
, vol.46
, pp. 560-566
-
-
Ribeiro, M.J.1
De Lonlay, P.2
Delzescaux, T.3
Boddaert, N.4
Jaubert, F.5
Bourgeois, S.6
-
12
-
-
55949127644
-
Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography
-
Kauhanen S, Seppänen M, Nuutila P. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography. J Clin Oncol 2008;26:5307-8.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5307-5308
-
-
Kauhanen, S.1
Seppänen, M.2
Nuutila, P.3
-
13
-
-
4043130985
-
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET
-
Becherer A, Szabó M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, et al. Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. J Nucl Med 2004;45:1161-7.
-
(2004)
J Nucl Med
, vol.45
, pp. 1161-1167
-
-
Becherer, A.1
Szabó, M.2
Karanikas, G.3
Wunderbaldinger, P.4
Angelberger, P.5
Raderer, M.6
-
15
-
-
84855797559
-
Is there an optimal scan time for 6-[F-18] fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
-
Hentschel M, Rottenburger C, Boedeker CC, Neumann HP, Brink I. Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Clin Nucl Med 2012;37(2):e24-9.
-
(2012)
Clin Nucl Med
, vol.37
, Issue.2
-
-
Hentschel, M.1
Rottenburger, C.2
Boedeker, C.C.3
Neumann, H.P.4
Brink, I.5
-
16
-
-
77952340573
-
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma
-
Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, et al. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid 2010;20 (5):527-33.
-
(2010)
Thyroid
, vol.20
, Issue.5
, pp. 527-533
-
-
Luster, M.1
Karges, W.2
Zeich, K.3
Pauls, S.4
Verburg, F.A.5
Dralle, H.6
-
20
-
-
33750584290
-
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
-
Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, et al. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med 2006;47(9):1455-62.
-
(2006)
J Nucl Med
, vol.47
, Issue.9
, pp. 1455-1462
-
-
Montravers, F.1
Grahek, D.2
Kerrou, K.3
Ruszniewski, P.4
De Beco, V.5
Aide, N.6
-
21
-
-
65249107298
-
Impact of fluorodihydroxyphenylalanine- 18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors
-
Montravers F, Kerrou K, Nataf V, Huchet V, Lotz JP, Ruszniewski P, et al. Impact of fluorodihydroxyphenylalanine- 18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab 2009;94(4):1295-301.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, Issue.4
, pp. 1295-1301
-
-
Montravers, F.1
Kerrou, K.2
Nataf, V.3
Huchet, V.4
Lotz, J.P.5
Ruszniewski, P.6
-
22
-
-
0034746433
-
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
-
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001;28:64-71.
-
(2001)
Eur J Nucl Med
, vol.28
, pp. 64-71
-
-
Hoegerle, S.1
Altehofer, C.2
Ghanem, N.3
Brink, I.4
Moser, E.5
Nitzsche, E.6
-
23
-
-
84865709685
-
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: A meta-analysis
-
Treglia G, Cocciolillo F, Di Nardo F, Poscia A, de Waure C, Giordano A, et al. Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis. Acad Radiol 2012;19 (10):1290-9.
-
(2012)
Acad Radiol
, vol.19
, Issue.10
, pp. 1290-1299
-
-
Treglia, G.1
Cocciolillo, F.2
Di Nardo, F.3
Poscia, A.4
De Waure, C.5
Giordano, A.6
-
24
-
-
28944433021
-
18F-choline, and 18Ffluoride in bone imaging with emphasis on prostate and breast
-
18F-choline, and 18Ffluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73-92.
-
(2006)
Semin Nucl Med
, vol.36
, pp. 73-92
-
-
Langsteger, W.1
Heinisch, M.2
Fogelman, I.3
-
28
-
-
77949270173
-
Dual PET/CT with (18)F-DOPA and (18)FFDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
-
Marzola MC, Pelizzo MR, Ferdeghini M, Toniato A, Massaro A, Ambrosini V, et al. Dual PET/CT with (18)F-DOPA and (18)FFDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: comparison with conventional imaging. Eur J Surg Oncol 2010;36(4):414-21.
-
(2010)
Eur J Surg Oncol
, vol.36
, Issue.4
, pp. 414-421
-
-
Marzola, M.C.1
Pelizzo, M.R.2
Ferdeghini, M.3
Toniato, A.4
Massaro, A.5
Ambrosini, V.6
-
31
-
-
78049336593
-
The prognostic value of 2-deoxy-2- [18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma
-
Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, et al. The prognostic value of 2-deoxy-2- [18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma. Mol Imaging Biol 2010;12(5):547-53.
-
(2010)
Mol Imaging Biol
, vol.12
, Issue.5
, pp. 547-553
-
-
Bogsrud, T.V.1
Karantanis, D.2
Nathan, M.A.3
Mullan, B.P.4
Wiseman, G.A.5
Kasperbauer, J.L.6
-
33
-
-
84889638082
-
Impact de la TEP à la fluoro-(18F)-dihydroxyphénylalanine (FDOPA) sur l'attitude thérapeutique en cas de tumeur endocrine: tumeur digestive cancer médullaire de la thyroïde ou phé ochromocytome
-
Montravers F, Grahek D, Kerrou K, Gutman F, Leverger G, Talbot J. Impact de la TEP à la fluoro-(18F)-dihydroxyphénylalanine (FDOPA) sur l'attitude thérapeutique en cas de tumeur endocrine: tumeur digestive, cancer médullaire de la thyroïde ou phéochromocytome. Med Nucl 2006;30(7):383-9.
-
(2006)
Med Nucl
, vol.30
, Issue.7
, pp. 383-389
-
-
Montravers, F.1
Grahek, D.2
Kerrou, K.3
Gutman, F.4
Leverger, G.5
Talbot, J.6
-
34
-
-
72949103236
-
Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma
-
Conry BG, Papathanasiou ND, Prakash V, Kayani I, Caplin M, Mahmood S, et al. Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2010;37(1):49-57.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, Issue.1
, pp. 49-57
-
-
Conry, B.G.1
Papathanasiou, N.D.2
Prakash, V.3
Kayani, I.4
Caplin, M.5
Mahmood, S.6
-
37
-
-
0034756055
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: Results of a multicentre study
-
Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 2001;28(11):1671-6.
-
(2001)
Eur J Nucl Med
, vol.28
, Issue.11
, pp. 1671-1676
-
-
Diehl, M.1
Risse, J.H.2
Brandt-Mainz, K.3
Dietlein, M.4
Bohuslavizki, K.H.5
Matheja, P.6
-
39
-
-
6944231270
-
18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer
-
18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 2004;11(8):786-94.
-
(2004)
Ann Surg Oncol
, vol.11
, Issue.8
, pp. 786-794
-
-
De Groot, J.W.1
Links, T.P.2
Jager, P.L.3
Kahraman, T.4
Plukker, J.T.5
-
40
-
-
16544377183
-
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: A clinical study and an analysis of the literature
-
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Commun 2004;25(5):439-43.
-
(2004)
Nucl Med Commun
, vol.25
, Issue.5
, pp. 439-443
-
-
Gotthardt, M.1
Battmann, A.2
Höffken, H.3
Schurrat, T.4
Pollum, H.5
Beuter, D.6
-
42
-
-
84863034134
-
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents
-
Lodish M, Dagalakis U, Chen CC, Sinaii N, Whitcomb P, Aikin A, et al. (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. J Clin Endocrinol Metab 2012;97(2):E207-12.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.2
-
-
Lodish, M.1
Dagalakis, U.2
Chen, C.C.3
Sinaii, N.4
Whitcomb, P.5
Aikin, A.6
-
43
-
-
67749130797
-
Medullary thyroid cancer: Management guidelines of the American Thyroid Association
-
American Thyroid Association Guidelines Task Force
-
American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19(6):565-612.
-
(2009)
Thyroid
, vol.19
, Issue.6
, pp. 565-612
-
-
Kloos, R.T.1
Eng, C.2
Evans, D.B.3
Francis, G.L.4
Gagel, R.F.5
Gharib, H.6
-
44
-
-
0026640848
-
Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan
-
Castagnoli A, Biti G, De Cristofaro MT, Ferri P, Magrini SM, Papi MG, et al. Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan. Eur J Nucl Med 1992;19(10):913-6.
-
(1992)
Eur J Nucl Med
, vol.19
, Issue.10
, pp. 913-916
-
-
Castagnoli, A.1
Biti, G.2
De Cristofaro, M.T.3
Ferri, P.4
Magrini, S.M.5
Papi, M.G.6
-
45
-
-
0026648238
-
Somatostatin receptor scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases
-
Kwekkeboom DJ, Hof AM, Lamberts SWJ, Oei HY, Krenning EP. Somatostatin receptor scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases. Arch Dermatol 1992;128:818-21.
-
(1992)
Arch Dermatol
, vol.128
, pp. 818-821
-
-
Kwekkeboom, D.J.1
Hof, A.M.2
Swj, L.3
Oei, H.Y.4
Krenning, E.P.5
-
46
-
-
0007857218
-
F-18 FDG accumulation in an octreotide negative Merkel cell tumor
-
Wong CO, Pham AN, Dworkin HJ. F-18 FDG accumulation in an octreotide negative Merkel cell tumor. Clin Positron Imaging 2000;3:71-3.
-
(2000)
Clin Positron Imaging
, vol.3
, pp. 71-73
-
-
Wong, C.O.1
Pham, A.N.2
Dworkin, H.J.3
-
47
-
-
33646791165
-
6-[F-18]Fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: Preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data
-
Talbot JN, Kerrou K, Missoum F, Grahek D, Aide N, Lumbroso J, et al. 6-[F-18]Fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D- glucose positron emission tomography or pentetreotide-(111In) SPECT data. Mol Imaging Biol 2005;7(4):257-61.
-
(2005)
Mol Imaging Biol
, vol.7
, Issue.4
, pp. 257-261
-
-
Talbot, J.N.1
Kerrou, K.2
Missoum, F.3
Grahek, D.4
Aide, N.5
Lumbroso, J.6
-
48
-
-
76549115351
-
Diagnostic imaging in Merkel cell carcinoma: Lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET
-
Peloschek P, Novotny C, Mueller-Mang C, Weber M, Sailer J, Dawid M, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol 2010;73(2):317-23.
-
(2010)
Eur J Radiol
, vol.73
, Issue.2
, pp. 317-323
-
-
Peloschek, P.1
Novotny, C.2
Mueller-Mang, C.3
Weber, M.4
Sailer, J.5
Dawid, M.6
-
49
-
-
84869100490
-
The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma
-
Colgan MB, Tarantola TI, Weaver AL, Wiseman GA, Roenigk RK, Brewer JD, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Acad Dermatol 2012;67(6):1250-6.
-
(2012)
J Am Acad Dermatol
, vol.67
, Issue.6
, pp. 1250-1256
-
-
Colgan, M.B.1
Tarantola, T.I.2
Weaver, A.L.3
Wiseman, G.A.4
Roenigk, R.K.5
Brewer, J.D.6
-
50
-
-
30944441516
-
FDG-PET imaging in Merkel cell carcinoma - Value of head-to-toe scan
-
Golan H, Volkov O, Linchinsky O, Melloul M. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan. Nucl Med Rev Cent East Eur 2005;8(2):135-6.
-
(2005)
Nucl Med Rev Cent East Eur
, vol.8
, Issue.2
, pp. 135-136
-
-
Golan, H.1
Volkov, O.2
Linchinsky, O.3
Melloul, M.4
-
52
-
-
33748535423
-
Clinical added-value of 18FDG PET in neuroendocrine-Merkel cell carcinoma
-
Belhocine T, Pierard GE, Frühling J, Letesson G, Bolle S, Hustinx R, et al. Clinical added-value of 18FDG PET in neuroendocrine-Merkel cell carcinoma. Oncol Rep 2006;16 (2):347-52.
-
(2006)
Oncol Rep
, vol.16
, Issue.2
, pp. 347-352
-
-
Belhocine, T.1
Pierard, G.E.2
Frühling, J.3
Letesson, G.4
Bolle, S.5
Hustinx, R.6
-
53
-
-
0035096765
-
Positron emission tomography in the staging of smallcell lung cancer: A preliminary study
-
Hauber HP, Bohuslaviki KH, Lund CH, Fritscher-Ravens A, Meyer A, Pforte A. Positron emission tomography in the staging of smallcell lung cancer: a preliminary study. Chest 2001;119(3):950-4.
-
(2001)
Chest
, vol.119
, Issue.3
, pp. 950-954
-
-
Hauber, H.P.1
Bohuslaviki, K.H.2
Lund, C.H.3
Fritscher-Ravens, A.4
Meyer, A.5
Pforte, A.6
-
54
-
-
12444304202
-
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: Preliminary results
-
Jacob T, Grahek D, Younsi N, Kerrou K, Aide N, Montravers F, et al. Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results. Eur J Nucl Med Mol Imaging 2003;30:1266-9.
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 1266-1269
-
-
Jacob, T.1
Grahek, D.2
Younsi, N.3
Kerrou, K.4
Aide, N.5
Montravers, F.6
-
55
-
-
19944428215
-
Impact of [18F]FDG-PET on the primary staging of smallcell lung cancer
-
Brink I, Schumacher T, Mix M, Ruhland S, Stoelben E, Digel W, et al. Impact of [18F]FDG-PET on the primary staging of smallcell lung cancer. Eur J Nucl Med Mol Imaging 2004;31:1614-20.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, pp. 1614-1620
-
-
Brink, I.1
Schumacher, T.2
Mix, M.3
Ruhland, S.4
Stoelben, E.5
Digel, W.6
-
56
-
-
36849015417
-
A pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome
-
Dubois S, Morel O, Rodien P, Illouz F, Girault S, Cahouet A, et al. A pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome. J Clin Endocrinol Metab 2007;92:4512-3.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 4512-4513
-
-
Dubois, S.1
Morel, O.2
Rodien, P.3
Illouz, F.4
Girault, S.5
Cahouet, A.6
-
59
-
-
0031898490
-
Evaluation of primary pulmonary carcinoid tumors using FDG PET
-
Erasmus JJ, McAdams HP, Patz Jr EF, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998;170:1369-73.
-
(1998)
AJR Am J Roentgenol
, vol.170
, pp. 1369-1373
-
-
Erasmus, J.J.1
McAdams, H.P.2
Patz Jr., E.F.3
Coleman, R.E.4
Ahuja, V.5
Goodman, P.C.6
-
60
-
-
33751116290
-
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours
-
Krüger S, Buck AK, Blumstein NM, Pauls S, Schelzig H, Kropf C, et al. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. J Intern Med 2006;260(6):545-50.
-
(2006)
J Intern Med
, vol.260
, Issue.6
, pp. 545-550
-
-
Krüger, S.1
Buck, A.K.2
Blumstein, N.M.3
Pauls, S.4
Schelzig, H.5
Kropf, C.6
-
61
-
-
33846315063
-
The utility of fluorodeoxyglucose emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules
-
Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR. The utility of fluorodeoxyglucose emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest 2007;131(1):255-60.
-
(2007)
Chest
, vol.131
, Issue.1
, pp. 255-260
-
-
Daniels, C.E.1
Lowe, V.J.2
Aubry, M.C.3
Allen, M.S.4
Jett, J.R.5
-
64
-
-
79960493573
-
Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids
-
Jindal T, Kumar A, Venkitaraman B, Meena M, Kumar R, Malhotra A, et al. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Cancer Imaging 2011;11:70-5.
-
(2011)
Cancer Imaging
, vol.11
, pp. 70-75
-
-
Jindal, T.1
Kumar, A.2
Venkitaraman, B.3
Meena, M.4
Kumar, R.5
Malhotra, A.6
-
65
-
-
50549199830
-
The classification of carcinoid tumours
-
Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963;i:238-9.
-
(1963)
Lancet
, vol.1
, pp. 238-239
-
-
Williams, E.D.1
Sandler, M.2
-
66
-
-
0037896855
-
[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas
-
van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, et al. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2001;86:685-93.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 685-693
-
-
Van Der Harst, E.1
De Herder, W.W.2
Bruining, H.A.3
Bonjer, H.J.4
De Krijger, R.R.5
Lamberts, S.W.6
-
67
-
-
0035528831
-
6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma
-
Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 2001;38:6-8.
-
(2001)
Hypertension
, vol.38
, pp. 6-8
-
-
Pacak, K.1
Eisenhofer, G.2
Carrasquillo, J.A.3
Chen, C.C.4
Li, S.T.5
Goldstein, D.S.6
-
68
-
-
34247179545
-
Whole-body PET/CT with 11C-metahydroxyephedrine in tumors of the sympathetic nervous system: Feasibility study and comparison with 123I-MIBG SPECT/CT
-
Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, et al. Whole-body PET/CT with 11C-metahydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med 2006;47(10):1635-42.
-
(2006)
J Nucl Med
, vol.47
, Issue.10
, pp. 1635-1642
-
-
Franzius, C.1
Hermann, K.2
Weckesser, M.3
Kopka, K.4
Juergens, K.U.5
Vormoor, J.6
-
69
-
-
84863595048
-
11CHydroxyephedrine positron emission tomography imaging of pheochromocytoma: A single center experience over 11 years
-
Yamamoto S, Hellman P, Wassberg C, Sundin A. 11CHydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years. J Clin Endocrinol Metab 2012;97(7):2423-32.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.7
, pp. 2423-2432
-
-
Yamamoto, S.1
Hellman, P.2
Wassberg, C.3
Sundin, A.4
-
70
-
-
0036007324
-
Pheochromocytomas: Detection with 18F DOPA whole body PET-initial results
-
Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al. Pheochromocytomas: detection with 18F DOPA whole body PET-initial results. Radiology 2002;222:507-12.
-
(2002)
Radiology
, vol.222
, pp. 507-512
-
-
Hoegerle, S.1
Nitzsche, E.2
Altehoefer, C.3
Ghanem, N.4
Manz, T.5
Brink, I.6
-
72
-
-
65549141729
-
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors
-
Kauhanen S, Seppänen M, Ovaska J, Minn H, Bergman J, Korsoff P, et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocr Relat Cancer 2009;16:255-65.
-
(2009)
Endocr Relat Cancer
, vol.16
, pp. 255-265
-
-
Kauhanen, S.1
Seppänen, M.2
Ovaska, J.3
Minn, H.4
Bergman, J.5
Korsoff, P.6
-
74
-
-
70349904742
-
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess
-
Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, et al. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 2009;94 (10):3922-30.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, Issue.10
, pp. 3922-3930
-
-
Fiebrich, H.B.1
Brouwers, A.H.2
Kerstens, M.N.3
Pijl, M.E.4
Kema, I.P.5
De Jong, J.R.6
-
76
-
-
78650369777
-
Comparison of [111In]pentetreotide-SPECT and [18F] FDOPA-PET in the localization of extra-adrenal paragangliomas: The case for a patient-tailored use of nuclear imaging modalities
-
Charrier N, Deveze A, Fakhry N, Sebag F, Morange I, Gaborit B, et al. Comparison of [111In]pentetreotide-SPECT and [18F] FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities. Clin Endocrinol (Oxf) 2011;74(1):21-9.
-
(2011)
Clin Endocrinol (Oxf)
, vol.74
, Issue.1
, pp. 21-29
-
-
Charrier, N.1
Deveze, A.2
Fakhry, N.3
Sebag, F.4
Morange, I.5
Gaborit, B.6
-
77
-
-
77954462618
-
18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: Correlation with vesicular monoamine transporter expression
-
18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. J Clin Endocrinol Metab 2010;95(6):2800-10.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, Issue.6
, pp. 2800-2810
-
-
Fottner, C.1
Helisch, A.2
Anlauf, M.3
Rossmann, H.4
Musholt, T.J.5
Kreft, A.6
-
78
-
-
80052545178
-
18F-fluorodopamine, 18Ffluoro- 2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy
-
18F-fluorodopamine, 18Ffluoro- 2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab 2011;96(9):2779-85.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, Issue.9
, pp. 2779-2785
-
-
King, K.S.1
Chen, C.C.2
Alexopoulos, D.K.3
Whatley, M.A.4
Reynolds, J.C.5
Patronas, N.6
-
79
-
-
79958772264
-
Comparison of 123I-MIBG SPECT-CT and 18FDOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma
-
Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, et al. Comparison of 123I-MIBG SPECT-CT and 18FDOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Nucl Med Commun 2011;32:575-82.
-
(2011)
Nucl Med Commun
, vol.32
, pp. 575-582
-
-
Rufini, V.1
Treglia, G.2
Castaldi, P.3
Perotti, G.4
Calcagni, M.L.5
Corsello, S.M.6
-
80
-
-
84869087919
-
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
-
Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 2012;39(12):1977-95.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, Issue.12
, pp. 1977-1995
-
-
Taïeb, D.1
Timmers, H.J.2
Hindié, E.3
Guillet, B.A.4
Neumann, H.P.5
Walz, M.K.6
-
81
-
-
84862668094
-
Diagnostic performance of 18Fdihydroxyphenylalanine positron emission tomography in patients with paraganglioma: A meta-analysis
-
Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, et al Diagnostic performance of 18Fdihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging 2012;39(7):1144-53.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, Issue.7
, pp. 1144-1153
-
-
Treglia, G.1
Cocciolillo, F.2
De Waure, C.3
Di Nardo, F.4
Gualano, M.R.5
Castaldi, P.6
-
83
-
-
84859528027
-
Clinical utility of functional imaging with 18FFDOPA in von Hippel-Lindau syndrome
-
Weisbrod AB, Kitano M, Gesuwan K, Millo C, Herscovitch P, Nilubol N, et al. Clinical utility of functional imaging with 18FFDOPA in Von Hippel-Lindau syndrome. J Clin Endocrinol Metab 2012;97(4):E613-7.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.4
-
-
Weisbrod, A.B.1
Kitano, M.2
Gesuwan, K.3
Millo, C.4
Herscovitch, P.5
Nilubol, N.6
-
85
-
-
0026654449
-
In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas
-
Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E, et al. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 1992;74:1082-9.
-
(1992)
J Clin Endocrinol Metab
, vol.74
, pp. 1082-1089
-
-
Reubi, J.C.1
Waser, B.2
Khosla, S.3
Kvols, L.4
Goellner, J.R.5
Krenning, E.6
-
87
-
-
84892911144
-
Evaluation of the impact of FDOPA-PET on the management of patients referred for pheochromocytoma
-
Montravers F, Kerrou K, Huchet V, Nataf V, Talbot JN. Evaluation of the impact of FDOPA-PET on the management of patients referred for pheochromocytoma. J Nucl Med 2008;49 (Suppl 1):365.
-
(2008)
J Nucl Med
, vol.49
, Issue.SUPPL. 1
, pp. 365
-
-
Montravers, F.1
Kerrou, K.2
Huchet, V.3
Nataf, V.4
Talbot, J.N.5
-
88
-
-
33847207873
-
Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors
-
Ezziddin S, Logvinski T, Yong-Hing C, Ahmadzadehfar H, Fischer HP, Palmedo H, et al. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors. J Nucl Med 2006;47:223-33.
-
(2006)
J Nucl Med
, vol.47
, pp. 223-233
-
-
Ezziddin, S.1
Logvinski, T.2
Yong-Hing, C.3
Ahmadzadehfar, H.4
Fischer, H.P.5
Palmedo, H.6
-
89
-
-
17744373472
-
Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors
-
Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, et al. Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:895-902.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 895-902
-
-
Kaltsas, G.1
Korbonits, M.2
Heintz, E.3
Mukherjee, J.J.4
Jenkins, P.J.5
Chew, S.L.6
-
90
-
-
0033062098
-
Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography
-
Hoegerle S, Schneider B, Kraft A, Moser E, Nitzsche EU. Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography. Nuklearmedizin 1999;38(4):127-30.
-
(1999)
Nuklearmedizin
, vol.38
, Issue.4
, pp. 127-130
-
-
Hoegerle, S.1
Schneider, B.2
Kraft, A.3
Moser, E.4
Nitzsche, E.U.5
-
91
-
-
0034742715
-
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors
-
Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001;220:373-80.
-
(2001)
Radiology
, vol.220
, pp. 373-380
-
-
Hoegerle, S.1
Altehoefer, C.2
Ghanem, N.3
Koehler, G.4
Waller, C.F.5
Scheruebl, H.6
-
92
-
-
0035089165
-
Functional imaging of malignant paragangliomas and carcinoid tumours
-
Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ. Functional imaging of malignant paragangliomas and carcinoid tumours. Eur J Nucl Med 2001;28(4):478-82.
-
(2001)
Eur J Nucl Med
, vol.28
, Issue.4
, pp. 478-482
-
-
Le Rest, C.1
Bomanji, J.B.2
Costa, D.C.3
Townsend, C.E.4
Visvikis, D.5
Ell, P.J.6
-
93
-
-
0035991806
-
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: Correlations with the pathological indexes p53 and Ki-67
-
Belhocine T, Foidart J, Rigo P, Najjar F, Thiry A, Quatresooz P, et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun 2002;23:727-34.
-
(2002)
Nucl Med Commun
, vol.23
, pp. 727-734
-
-
Belhocine, T.1
Foidart, J.2
Rigo, P.3
Najjar, F.4
Thiry, A.5
Quatresooz, P.6
-
94
-
-
68749092790
-
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F] fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients
-
Fiebrich HB, Brouwers AH, Koopmans KP, de Vries EG. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F] fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients. Eur J Cancer 2009;45(13):2312-5.
-
(2009)
Eur J Cancer
, vol.45
, Issue.13
, pp. 2312-2315
-
-
Fiebrich, H.B.1
Brouwers, A.H.2
Koopmans, K.P.3
De Vries, E.G.4
-
95
-
-
84862640505
-
The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: A US population-based study
-
Amin S,Warner RR, Itzkowitz SH, KimMK. The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study. Endocr Relat Cancer 2012;19(3):381-7.
-
(2012)
Endocr Relat Cancer
, vol.19
, Issue.3
, pp. 381-387
-
-
Amin, S.1
Warner, R.R.2
Itzkowitz, S.H.3
Kim, M.K.4
-
98
-
-
84892932787
-
Comparison of FDOPA (18F) and DOTATOC (68Ga) PET/CT for detection of ileal carcinoid tumours
-
abs OP586
-
Montravers F, Nataf V, Balogova S, Calzada M, Maurel G, Kerrou K, et al. Comparison of FDOPA (18F) and DOTATOC (68Ga) PET/CT for detection of ileal carcinoid tumours. Eur J Nucl Med Mol Imaging 2010;37(S2):S302. abs OP586.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, Issue.S2
-
-
Montravers, F.1
Nataf, V.2
Balogova, S.3
Calzada, M.4
Maurel, G.5
Kerrou, K.6
-
100
-
-
84872826979
-
Gastroenteric neuroendocrine neoplasms classification: Comparison of prognostic models
-
Dolcetta-Capuzzo A, Villa V, Albarello L, Franchi GM, Gemma M, Scavini M, et al. Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models. Cancer 2013;119(1):36-44.
-
(2013)
Cancer
, vol.119
, Issue.1
, pp. 36-44
-
-
Dolcetta-Capuzzo, A.1
Villa, V.2
Albarello, L.3
Franchi, G.M.4
Gemma, M.5
Scavini, M.6
-
101
-
-
55449128279
-
F-18-FDGPET/CT imaging of small cell carcinoma of the colon
-
Jones K, Subramaniam RM, Durnick DK, Peller PJ. F-18-FDGPET/CT imaging of small cell carcinoma of the colon. Clin Nucl Med 2008;33(9):645-6.
-
(2008)
Clin Nucl Med
, vol.33
, Issue.9
, pp. 645-646
-
-
Jones, K.1
Subramaniam, R.M.2
Durnick, D.K.3
Peller, P.J.4
-
102
-
-
84655175045
-
Highgrade neuroendocrine carcinoma of the colon, long-term survival in advanced disease
-
Power DG, Asmis TR, Tang LH, Brown K, Kemeny NE. Highgrade neuroendocrine carcinoma of the colon, long-term survival in advanced disease. Med Oncol 2011;28 Suppl 1:S169-74.
-
(2011)
Med Oncol
, vol.28 SUPPL. 1
-
-
Power, D.G.1
Asmis, T.R.2
Tang, L.H.3
Brown, K.4
Kemeny, N.E.5
-
103
-
-
0028962933
-
Pancreatic neuroendocrine tumors: Diagnosis with PET
-
Ahlström H, Eriksson B, Bergström M, Bjurling P, Langström B, Oberg K. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995;195:333-7.
-
(1995)
Radiology
, vol.195
, pp. 333-337
-
-
Ahlström, H.1
Eriksson, B.2
Bergström, M.3
Bjurling, P.4
Langström, B.5
Oberg, K.6
-
104
-
-
79960296365
-
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
-
Wild D, Christ E, Caplin ME, Kurzawinski TR, Forrer F, Brändle M, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011;52(7):1073-8.
-
(2011)
J Nucl Med
, vol.52
, Issue.7
, pp. 1073-1078
-
-
Wild, D.1
Christ, E.2
Caplin, M.E.3
Kurzawinski, T.R.4
Forrer, F.5
Brändle, M.6
-
105
-
-
34147154971
-
Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients
-
Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, et al. Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients. J Clin Endocrinol Metab 2007;92:1237-44.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 1237-1244
-
-
Kauhanen, S.1
Seppänen, M.2
Minn, H.3
Gullichsen, R.4
Salonen, A.5
Alanen, K.6
-
107
-
-
77952519078
-
Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L- dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients
-
Putzer D, Gabriel M, Kendler D, Henninger B, Knoflach M, Kroiss A, et al. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L- dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients. Q J Nucl Med Mol Imaging 2010;54(1):68-75.
-
(2010)
Q J Nucl Med Mol Imaging
, vol.54
, Issue.1
, pp. 68-75
-
-
Putzer, D.1
Gabriel, M.2
Kendler, D.3
Henninger, B.4
Knoflach, M.5
Kroiss, A.6
-
108
-
-
79952302230
-
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10 %) well-differentiated endocrine carcinoma staging
-
Abgral R, Leboulleux S, Déandreis D, Aupérin A, Lumbroso J, Dromain C, et al. Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10 %) well-differentiated endocrine carcinoma staging. J Clin Endocrinol Metab 2011;96(3):665-71.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, Issue.3
, pp. 665-671
-
-
Abgral, R.1
Leboulleux, S.2
Déandreis, D.3
Aupérin, A.4
Lumbroso, J.5
Dromain, C.6
-
109
-
-
36749056733
-
The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: A retrospective study involving 49 children
-
Ribeiro MJ, Boddaert N, Bellanné-Chantelot C, Bourgeois S, Valayannopoulos V, Delzescaux T, et al. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging 2007;34(12):2120-8.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, Issue.12
, pp. 2120-2128
-
-
Ribeiro, M.J.1
Boddaert, N.2
Bellanné-Chantelot, C.3
Bourgeois, S.4
Valayannopoulos, V.5
Delzescaux, T.6
-
110
-
-
33644782807
-
Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography
-
Otonkoski T, Näntö-Salonen K, Seppänen M, Veijola R, Huopio H, Hussain K, et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 2006;55:13-8.
-
(2006)
Diabetes
, vol.55
, pp. 13-18
-
-
Otonkoski, T.1
Näntö-Salonen, K.2
Seppänen, M.3
Veijola, R.4
Huopio, H.5
Hussain, K.6
-
111
-
-
36849049798
-
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism
-
Hardy OT, Hernandez-Pampaloni M, Saffer JR, Sheuermann JS, Ernst LM, Freifelder R, et al. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 2007;92:4706-11.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 4706-4711
-
-
Hardy, O.T.1
Hernandez-Pampaloni, M.2
Saffer, J.R.3
Sheuermann, J.S.4
Ernst, L.M.5
Freifelder, R.6
-
113
-
-
78751518250
-
The predictive value of preoperative fluorine-18-L-3,4- dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy
-
Zani A, Nah SA, Ron O, Totonelli G, Ismail D, Smith VV, et al. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. J Pediatr Surg 2011;46(1):204-8.
-
(2011)
J Pediatr Surg
, vol.46
, Issue.1
, pp. 204-208
-
-
Zani, A.1
Nah, S.A.2
Ron, O.3
Totonelli, G.4
Ismail, D.5
Smith, V.V.6
-
114
-
-
78650492859
-
Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism
-
Mohnike W, Barthlen W, Mohnike K, Blankenstein O. Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L- dihydroxyphenylalanine in congenital hyperinsulinism. Semin Pediatr Surg 2011;20(1):23-7.
-
(2011)
Semin Pediatr Surg
, vol.20
, Issue.1
, pp. 23-27
-
-
Mohnike, W.1
Barthlen, W.2
Mohnike, K.3
Blankenstein, O.4
-
115
-
-
84872269935
-
Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: A meta-analysis
-
TregliaG,Mirk P, GiordanoA, Rufini V. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis. Pediatr Radiol 2012;42(11):1372-9.
-
(2012)
Pediatr Radiol
, vol.42
, Issue.11
, pp. 1372-1379
-
-
Treglia, G.1
Mirk, P.2
Giordano, A.3
Rufini, V.4
-
116
-
-
84873090830
-
The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: Systematic review and meta-analysis
-
Blomberg BA,MoghbelMC, Saboury B, Stanley CA, Alavi A. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol 2013;15:97-105.
-
(2013)
Mol Imaging Biol
, vol.15
, pp. 97-105
-
-
Blomberg, B.A.1
Moghbel, M.C.2
Saboury, B.3
Stanley, C.A.4
Alavi, A.5
-
117
-
-
33748186497
-
F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases
-
Iagaru A, Gamie S, Segall G. F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases. Clin Nucl Med 2006;31(8):476-8.
-
(2006)
Clin Nucl Med
, vol.31
, Issue.8
, pp. 476-478
-
-
Iagaru, A.1
Gamie, S.2
Segall, G.3
-
118
-
-
35748939974
-
Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D- glucose PET in a patient with thymic carcinoid
-
Fujishita T, Kishida M, Taki H, Shinoda C, Miyabayashi K, Fujishita M, et al. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D- glucose PET in a patient with thymic carcinoid. Respirology 2007;12(6):928-30.
-
(2007)
Respirology
, vol.12
, Issue.6
, pp. 928-930
-
-
Fujishita, T.1
Kishida, M.2
Taki, H.3
Shinoda, C.4
Miyabayashi, K.5
Fujishita, M.6
-
119
-
-
71049183148
-
Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years
-
Kobashi Y, Shimizu H, Mouri K, Irei T, Oka M. Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years. Intern Med 2009;48(21):1919-23.
-
(2009)
Intern Med
, vol.48
, Issue.21
, pp. 1919-1923
-
-
Kobashi, Y.1
Shimizu, H.2
Mouri, K.3
Irei, T.4
Oka, M.5
-
120
-
-
78649612713
-
Thymic neuroendocrine tumour (carcinoid): Clinicopathological features of four patients with different presentation
-
Dutta R, Kumar A, Julka PK, Mathur SR, Kaushal S, Kumar R, et al. Thymic neuroendocrine tumour (carcinoid): clinicopathological features of four patients with different presentation. Interact Cardiovasc Thorac Surg 2010;11(6):732-6.
-
(2010)
Interact Cardiovasc Thorac Surg
, vol.11
, Issue.6
, pp. 732-736
-
-
Dutta, R.1
Kumar, A.2
Julka, P.K.3
Mathur, S.R.4
Kaushal, S.5
Kumar, R.6
-
121
-
-
0036135042
-
Diagnosing and treating smallcell carcinomas of prostatic origin
-
Spieth ME, Lin YG, Nguyen TT. Diagnosing and treating smallcell carcinomas of prostatic origin. Clin Nucl Med 2002;27 (1):11-7.
-
(2002)
Clin Nucl Med
, vol.27
, Issue.1
, pp. 11-17
-
-
Spieth, M.E.1
Lin, Y.G.2
Nguyen, T.T.3
-
122
-
-
41949128292
-
Smallcell carcinoma of the prostate
-
Anker CJ, Dechet C, Isaac JC, Akerley W, Shrieve DC. Smallcell carcinoma of the prostate. J Clin Oncol 2008;26:1168-71.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1168-1171
-
-
Anker, C.J.1
Dechet, C.2
Isaac, J.C.3
Akerley, W.4
Shrieve, D.C.5
-
123
-
-
70350119789
-
Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT
-
Yilmaz M, Celen Z, Sevinc A, Karakok M. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT. Clin Nucl Med 2009;34:598-600.
-
(2009)
Clin Nucl Med
, vol.34
, pp. 598-600
-
-
Yilmaz, M.1
Celen, Z.2
Sevinc, A.3
Karakok, M.4
-
124
-
-
77952540811
-
F-18 FDG PET/CT imaging in small cell prostate cancer
-
de Carvalho Flamini R, Yamaga L, Mello ME, Wagner J, Livorsi Da Cunha M, Osawa A, et al. F-18 FDG PET/CT imaging in small cell prostate cancer. Clin Nucl Med 2010;35:452-3.
-
(2010)
Clin Nucl Med
, vol.35
, pp. 452-453
-
-
De Carvalho Flamini, R.1
Yamaga, L.2
Mello, M.E.3
Wagner, J.4
Livorsi Da Cunha, M.5
Osawa, A.6
-
125
-
-
84855195252
-
Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate
-
Brammer JE, Lulla P, Lynch GR. Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J Clin Oncol 2011;16(6):722-5.
-
(2011)
Int J Clin Oncol
, vol.16
, Issue.6
, pp. 722-725
-
-
Brammer, J.E.1
Lulla, P.2
Lynch, G.R.3
-
126
-
-
84856723290
-
Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors
-
Miljkovi? MD, Girotra M, Abraham RR, Erlich RB. Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors. Dig Dis Sci 2012;57(1):9-18.
-
(2012)
Dig Dis Sci
, vol.57
, Issue.1
, pp. 9-18
-
-
Miljkovi, M.D.1
Girotra, M.2
Abraham, R.R.3
Erlich, R.B.4
-
128
-
-
40849114945
-
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases
-
Schmitt AM, Riniker F, AnlaufM, Schmid S, Soltermann A,Moch H, et al. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 2008;32(3):420-5.
-
(2008)
Am J Surg Pathol
, vol.32
, Issue.3
, pp. 420-425
-
-
Schmitt, A.M.1
Riniker, F.2
Anlauf, M.3
Schmid, S.4
Soltermann, A.5
Moch, H.6
-
129
-
-
84859888884
-
PDX-1 CDX-2 TTF-1, and CK7: A reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms
-
Chan ES, Alexander J, Swanson PE, Jain D, Yeh MM. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol 2012;36(5):737-43.
-
(2012)
Am J Surg Pathol
, vol.36
, Issue.5
, pp. 737-743
-
-
Chan, E.S.1
Alexander, J.2
Swanson, P.E.3
Jain, D.4
Yeh, M.M.5
-
130
-
-
78349282294
-
68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors
-
68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 2010;252(5):850-6.
-
(2010)
Ann Surg
, vol.252
, Issue.5
, pp. 850-856
-
-
Frilling, A.1
Sotiropoulos, G.C.2
Amalagom, R.3
Bockisch, A.4
Kuehl, H.5
-
131
-
-
72949100074
-
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT
-
Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging 2010;37(1):67-77.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, Issue.1
, pp. 67-77
-
-
Prasad, V.1
Ambrosini, V.2
Hommann, M.3
Hoersch, D.4
Fanti, S.5
Baum, R.P.6
-
133
-
-
80054731691
-
Ectopic ACTH-syndrome due to a neuroendocrine tumour of the appendix
-
Perakakis N, Laubner K, Keck T, Steffl D, Lausch M,Meyer PT, et al. Ectopic ACTH-syndrome due to a neuroendocrine tumour of the appendix. Exp Clin Endocrinol Diabetes 2011;119(9):525-9.
-
(2011)
Exp Clin Endocrinol Diabetes
, vol.119
, Issue.9
, pp. 525-529
-
-
Perakakis, N.1
Laubner, K.2
Keck, T.3
Steffl, D.4
Lausch, M.5
Meyer, P.T.6
-
134
-
-
84865613008
-
68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome
-
68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome. Clin Nucl Med 2012;37(9):904-5.
-
(2012)
Clin Nucl Med
, vol.37
, Issue.9
, pp. 904-905
-
-
Schalin-Jäntti, C.1
Ahonen, A.2
Seppänen, M.3
-
135
-
-
17744381182
-
[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome
-
Markou A,Manning P, Kaya B,Datta SN, Bomanji JB, Conway GS. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome. Eur J Endocrinol 2005;152(4):521-5.
-
(2005)
Eur J Endocrinol
, vol.152
, Issue.4
, pp. 521-525
-
-
Markou, A.1
Manning, P.2
Kaya, B.3
Datta, S.N.4
Bomanji, J.B.5
Conway, G.S.6
-
136
-
-
50049109259
-
Thymic carcinoid tumor revealed by aCushings' syndrome: Usefulness of positron emission tomography
-
Gomard-Mennesson E, Sève P, De La Roche E, Collardeau- Frachon S, Lombard-Bohas C, Broussolle C. Thymic carcinoid tumor revealed by aCushings' syndrome: usefulness of positron emission tomography. Rev Med Interne 2008;29(9):751-3.
-
(2008)
Rev Med Interne
, vol.29
, Issue.9
, pp. 751-753
-
-
Gomard-Mennesson, E.1
Sève, P.2
De La Roche, E.3
Collardeau-Frachon, S.4
Lombard-Bohas, C.5
Broussolle, C.6
-
137
-
-
34347210987
-
Primary hepatic carcinoid tumor presenting as Cushing's syndrome
-
Shah NA, Urusova IA, D'Agnolo A, Colquhoun SD, Rosenbloom BE, Vener SL, et al. Primary hepatic carcinoid tumor presenting as Cushing's syndrome. J Endocrinol Invest 2007;30(4):327-33.
-
(2007)
J Endocrinol Invest
, vol.30
, Issue.4
, pp. 327-333
-
-
Shah, N.A.1
Urusova, I.A.2
D'agnolo, A.3
Colquhoun, S.D.4
Rosenbloom, B.E.5
Vener, S.L.6
-
138
-
-
78049347762
-
The value of 11C-5-hydroxytryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: Experience from one center
-
Nikolaou A, Thomas D, Kampanellou C, Alexandraki K, Andersson LG, Sundin A, et al. The value of 11C-5-hydroxytryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center. J Endocrinol Invest 2010;33(11):794-9.
-
(2010)
J Endocrinol Invest
, vol.33
, Issue.11
, pp. 794-799
-
-
Nikolaou, A.1
Thomas, D.2
Kampanellou, C.3
Alexandraki, K.4
Andersson, L.G.5
Sundin, A.6
-
139
-
-
77956960802
-
Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum
-
Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, et al. Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes 2010;118(8):524-9.
-
(2010)
Exp Clin Endocrinol Diabetes
, vol.118
, Issue.8
, pp. 524-529
-
-
Singer, J.1
Werner, F.2
Koch, C.A.3
Bartels, M.4
Aigner, T.5
Lincke, T.6
-
140
-
-
84857057951
-
An unusual case of ectopic ACTH syndrome
-
Willhauck MJ, Pöpperl G, Rachinger W, Giese A, Auernhammer CJ, Spitzweg C. An unusual case of ectopic ACTH syndrome. Exp Clin Endocrinol Diabetes 2012;120(2):63-7.
-
(2012)
Exp Clin Endocrinol Diabetes
, vol.120
, Issue.2
, pp. 63-67
-
-
Willhauck, M.J.1
Pöpperl, G.2
Rachinger, W.3
Giese, A.4
Auernhammer, C.J.5
Spitzweg, C.6
-
141
-
-
77749270829
-
Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropinsecreting tumors
-
Zemskova MS, Gundabolu B, Sinaii N, Chen CC, Carrasquillo JA, Whatley M, et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropinsecreting tumors. J Clin Endocrinol Metab 2010;95(3):1207-19.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, Issue.3
, pp. 1207-1219
-
-
Zemskova, M.S.1
Gundabolu, B.2
Sinaii, N.3
Chen, C.C.4
Carrasquillo, J.A.5
Whatley, M.6
-
143
-
-
84872117156
-
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
-
Froeling V, Elgeti F, Maurer MH, Scheurig-Muenkler C, Beck A, Kroencke TJ, et al. Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. Ann Nucl Med 2012;26(9):738-43.
-
(2012)
Ann Nucl Med
, vol.26
, Issue.9
, pp. 738-743
-
-
Froeling, V.1
Elgeti, F.2
Maurer, M.H.3
Scheurig-Muenkler, C.4
Beck, A.5
Kroencke, T.J.6
-
144
-
-
0037329190
-
Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]- fluorodopamine positron emission tomography
-
Gourgiotis L, Sarlis NJ, Reynolds JC, VanWaes C, Merino MJ, Pacak K. Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]- fluorodopamine positron emission tomography. J Clin Endocrinol Metab 2003;88(2):637-41.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, Issue.2
, pp. 637-641
-
-
Gourgiotis, L.1
Sarlis, N.J.2
Reynolds, J.C.3
Vanwaes, C.4
Merino, M.J.5
Pacak, K.6
-
145
-
-
10744225118
-
FDG PET imaging in hereditary thyroid cancer
-
Boér A, Szakàll Jr S, Klein I, Kàsler M, Vincze B, Trón L, et al. FDG PET imaging in hereditary thyroid cancer. Eur J Surg Oncol 2003;29(10):922-8.
-
(2003)
Eur J Surg Oncol
, vol.29
, Issue.10
, pp. 922-928
-
-
Boér, A.1
Szakàll Jr., S.2
Klein, I.3
Kàsler, M.4
Vincze, B.5
Trón, L.6
-
146
-
-
77951768869
-
Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer
-
Skoura E, Rondogianni P, Alevizaki M, Tzanela M, Tsagarakis S, Piaditis G, et al. Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer. Nucl Med Commun 2010;31(6):567-75.
-
(2010)
Nucl Med Commun
, vol.31
, Issue.6
, pp. 567-575
-
-
Skoura, E.1
Rondogianni, P.2
Alevizaki, M.3
Tzanela, M.4
Tsagarakis, S.5
Piaditis, G.6
-
147
-
-
77951815580
-
Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours
-
Schiesser M, Veit-Haibach P, Muller MK, Weber M, Bauerfeind P, Hany T, et al. Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours. Br J Surg 2010;97(5):691-7.
-
(2010)
Br J Surg
, vol.97
, Issue.5
, pp. 691-697
-
-
Schiesser, M.1
Veit-Haibach, P.2
Muller, M.K.3
Weber, M.4
Bauerfeind, P.5
Hany, T.6
-
150
-
-
0005924729
-
Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: A case-control study
-
Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, et al. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Aliment Pharmacol Ther 1999;13(2):145-53.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, Issue.2
, pp. 145-153
-
-
Sanduleanu, S.1
Stridsberg, M.2
Jonkers, D.3
Hameeteman, W.4
Biemond, I.5
Lundqvist, G.6
-
151
-
-
84866145912
-
Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects
-
Mosli HH, Dennis A, Kocha W, Asher LJ, Van Uum SH. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. J Clin Endocrinol Metab 2012;97(9):E1731-5.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.9
-
-
Mosli, H.H.1
Dennis, A.2
Kocha, W.3
Asher, L.J.4
Van Uum, S.H.5
-
152
-
-
84859965815
-
A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans
-
Raines D, Chester M, Diebold AE, Mamikunian P, Anthony CT, Mamikunian G, et al. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Pancreas 2012;41(4):508-11.
-
(2012)
Pancreas
, vol.41
, Issue.4
, pp. 508-511
-
-
Raines, D.1
Chester, M.2
Diebold, A.E.3
Mamikunian, P.4
Anthony, C.T.5
Mamikunian, G.6
-
153
-
-
0025072263
-
New solid-phase enzyme immunoassay of neuron-specific enolase in serum: Effect of storage temperature, lipemia, icterus, and hemolysis
-
Mercer DW, Virji MA, Barry GE, Piper ML. New solid-phase enzyme immunoassay of neuron-specific enolase in serum: effect of storage temperature, lipemia, icterus, and hemolysis. Clin Chem 1990;36(8 Pt 1):1519.
-
(1990)
Clin Chem
, vol.36 PART 1
, Issue.8
, pp. 1519
-
-
Mercer, D.W.1
Virji, M.A.2
Barry, G.E.3
Piper, M.L.4
|